Full Text View
Tabular View
No Study Results Posted
Related Studies
Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer
This study has been completed.
Study NCT00058071   Information provided by National Cancer Institute (NCI)
First Received: April 7, 2003   Last Updated: May 9, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Gestational Trophoblastic Tumor
Neurotoxicity
Additional conditions recognized in this trial
Gestational Trophoblastic Neoplasms
Neurotoxicity Syndromes
Peripheral Nervous System Diseases
Trophoblastic Neoplasms
More general conditions related to this trial
Disorders of Environmental Origin
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Nervous System Diseases
Neuromuscular Diseases
Poisoning
Pregnancy Complications
Pregnancy Complications, Neoplastic
Interventions listed in this trial
amifostine trihydrate
Additional drug interventions recognized in this trial
Amifostine
More general drug interventions related to this trial
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Radiation-Protective Agents
Sponsors listed in this trial
Gynecologic Oncology Group
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services